Satsuma Pharmaceuticals, Inc.
STSADelisted Jun 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001692830
Satsuma Pharmaceuticals, Inc. was delisted on Jun 8, 2023; its insiders filed their last Form 4 on Jun 12, 2023; 31 institutions reported holding it in 13F filings for Q1 2023, worth $12.7M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Satsuma Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 35 | 36 | +1 |
| Shares | 23.0M | 23.1M | +44.1K (+0.2%) |
| Value | $103.6M | $87.7M | −$16.0M (−15.4%) |
New holders (4)
Institutions that held Satsuma Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Walleye Capital LLC | 261,813 | $995.0K | 0.03% |
| Barclays PLC | 202,478 | $769.0K | 0.00% |
| FMR LLC | 2,163 | $8.00K | 0.00% |
| Royal Bank of Canada | 93 | $0 | 0.00% |
Sold out (3)
Institutions that held Satsuma Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Healthcare of Ontario Pension Plan Trust Fund | 68,600 | $309.0K |
| Engineers Gate Manager LP | 11,273 | $51.0K |
| Bank of America Corp | 4,297 | $19.0K |